Shamik Ghosh

New Delhi, DL, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

An update on the myriad antifungal resistance mechanisms in dermatophytes and the place of experimental and existential therapeutic agents for Trichophyton complex implicated in tinea corporis and cruris.

An update on the myriad antifungal resistance mechanisms in dermatophytes and the place of experimental and existential therapeutic agents for Trichophyton complex implicated in tinea corporis and cruris.

Journal: Expert review of anti-infective therapy
Published: August 22, 2023

Treatment recalcitrant cases of tinea corporis/cruris caused by T. mentagrophytes - interdigitale complex with mutations in ERG11 ERG 3, ERG4, MDR1 MFS genes & SQLE and their potential implications.

Treatment recalcitrant cases of tinea corporis/cruris caused by T. mentagrophytes - interdigitale complex with mutations in ERG11 ERG 3, ERG4, MDR1 MFS genes & SQLE and their potential implications.

Journal: International journal of dermatology
Published: July 20, 2022

Checkerboard Analysis To Evaluate Synergistic Combinations of Existing Antifungal Drugs and Propylene Glycol Monocaprylate in Isolates from Recalcitrant Tinea Corporis and Cruris Patients Harboring Squalene Epoxidase Gene Mutation.

Checkerboard Analysis To Evaluate Synergistic Combinations of Existing Antifungal Drugs and Propylene Glycol Monocaprylate in Isolates from Recalcitrant Tinea Corporis and Cruris Patients Harboring Squalene Epoxidase Gene Mutation.

Journal: Antimicrobial agents and chemotherapy
Published: June 07, 2021

A potent antibiotic-loaded bone-cement implant against staphylococcal bone infections.

A potent antibiotic-loaded bone-cement implant against staphylococcal bone infections.

Journal: Nature biomedical engineering
Published: May 10, 2020

Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.

Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.

Journal: Drugs in R&D
Published: March 31, 2020

Mechanistic Insight Into the Antifungal Effects of a Fatty Acid Derivative Against Drug-Resistant Fungal Infections.

Mechanistic Insight Into the Antifungal Effects of a Fatty Acid Derivative Against Drug-Resistant Fungal Infections.

Journal: Frontiers in microbiology
Published: March 03, 2020

Newly Developed Anti-Dandruff Regimen, VB-3222, Delivers Enhanced Sensorial and Effective Therapeutic Benefits Against Moderate Adherent Dandruff.

Newly Developed Anti-Dandruff Regimen, VB-3222, Delivers Enhanced Sensorial and Effective Therapeutic Benefits Against Moderate Adherent Dandruff.

Journal: Clinical, cosmetic and investigational dermatology
Published: June 14, 2019

A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne.

A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne.

Journal: The Journal of investigative dermatology
Published: November 24, 2016

Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff.

Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff.

Journal: BMC dermatology
Published: September 09, 2016

Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.

Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.

Journal: Dermatologic therapy
Published: July 19, 2016

Antibiotic-resistant acne: getting under the skin.

Antibiotic-resistant acne: getting under the skin.

Journal: Seminars in cutaneous medicine and surgery
Published: July 15, 2016
Showing 1-11 of 11

Last Updated: 09/26/2026